MOR1--MU OPIOID RECEPTORS AND THEIR ENDOGENOUS LIGANDS
MOR1--MU阿片受体及其内源性配体
基本信息
- 批准号:6104189
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The cloning of each of the pharmacologically identified types of opioid
receptors (i.e., delta, mu and kappa) has dramatically altered the nature
of the questions that can be addressed in the problem of the mismatch
between opioid receptors and their endogenous ligands. Two questions that
arise are: "Do the cloned receptors account for all of the opioid
receptors in the nervous system?" and "Do the identified endogenous
ligands represent the complete set of ligands available for action at
opioid receptors?"
With the successful production of a mu opioid knockout mouse and the
isolation and characterization of a new family of neuropeptides (the
endomorphins) that are active in mu receptors, these questions can be
addressed in novel ways. It is with this in mind that we propose
experiments that will contribute to the realization of the following
specific aims:
1) Determine if the cloned mu receptor, MOR1, is the mu receptor
responsible for presynaptic inhibition of norepinephrine release from
axons of locus coeruleus neurons.
2) Determine the biosynthetic precursor responsible for synthesis of
endomorphin, and the regional distribution of cells that express the
transcript for endomorphin and its biologically active products.
3) Determine the spatial relationship between the endomorphin peptides and
MOR1.
4) Determine if the expression of endomorphin is altered in mice that lack
the apparent cognate receptor (MOR1).
These aims will be accomplished by several different types of experiments.
Synaptosomal preparations of the forebrain of wild type and mu knockout
mice will help to elucidate the extend to which MOR1 is responsible for
the presynaptic inhibition of norepinephrine release. Also, proposed are
expression cloning experiments to isolate the biosynthetic precursor of
the endomorphins, followed by in situ hybridization studies. Finally, we
propose the development of specific antisera to the endomorphins and
subsequent two-color immunofluorescent experiments in wild type and
knockout mice to determine the extent of match between the cloned mu
receptor and this new family of endogenous ligands.
克隆每一种经药理学鉴定的阿片类药物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT P ELDE其他文献
ROBERT P ELDE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT P ELDE', 18)}}的其他基金
Subcellular Targeting/Packaging of Opioids/Receptors
阿片类药物/受体的亚细胞靶向/包装
- 批准号:
7513848 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MOR1--MU OPIOID RECEPTORS AND THEIR ENDOGENOUS LIGANDS
MOR1--MU阿片受体及其内源性配体
- 批准号:
6338711 - 财政年份:2000
- 资助金额:
-- - 项目类别:
MOR1--MU OPIOID RECEPTORS AND THEIR ENDOGENOUS LIGANDS
MOR1--MU阿片受体及其内源性配体
- 批准号:
6201640 - 财政年份:1999
- 资助金额:
-- - 项目类别:
SUBCELLULAR LOCALIZATION OF NEURONAL SITES OF OPIOID PEPTIDE RELEASE
阿片肽释放神经元位点的亚细胞定位
- 批准号:
6237946 - 财政年份:1997
- 资助金额:
-- - 项目类别:
相似海外基金
Elucidating the universality and specificity of reproductive mechanisms between species using genetically modified animals
使用转基因动物阐明物种间生殖机制的普遍性和特异性
- 批准号:
21H02397 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular cytological clarification of pathogenesis of male infertility by analyzing genetically modified animals and its clinical application
转基因动物分子细胞学阐明男性不育发病机制及其临床应用
- 批准号:
19K09665 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the processing mechanism of reactive oxygen species in the inner ear in MnSOD genetically modified animals
阐明MnSOD转基因动物内耳活性氧的加工机制
- 批准号:
15H06174 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Research Activity Start-up
Analysis of mammalian germ cell-specific GPI-anchored proteins using genetically modified animals
使用转基因动物分析哺乳动物生殖细胞特异性 GPI 锚定蛋白
- 批准号:
15H05573 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Young Scientists (A)
Research on the apelin as a therapeutic target molecule in ischemic retinopathy using genetically modified animals
使用转基因动物进行 apelin 作为缺血性视网膜病变治疗靶分子的研究
- 批准号:
24590131 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of D-serine-related gene and elucidation of etiology of schizophrenia using genetically modified animals
利用转基因动物鉴定D-丝氨酸相关基因并阐明精神分裂症的病因
- 批准号:
21590292 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular and morphological analysis of RNA helicase that shows an unique expression in the nervous system by utilizing genetically modified animals
利用转基因动物对 RNA 解旋酶进行分子和形态学分析,该酶在神经系统中显示出独特的表达
- 批准号:
21590198 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on the onset and progression of amyotrophic lateral sclerosis using genetically modified animals
使用转基因动物研究肌萎缩侧索硬化症的发病和进展
- 批准号:
21590110 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on cell-specific roles of nudear factor KB in the progression of renal diseases with genetically modified animals
核因子KB在转基因动物肾脏疾病进展中的细胞特异性作用研究
- 批准号:
18590903 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




